TD-2749 - CAS 863248-59-3

TD-2749 is a selective 5-HT4 agonist discovered by Theravance through multivalent compound design as part of a compound discovery project aimed at finding new treatments for gastrointestinal motility disorders. It is primarily used to treat chronic constipation, constipation-predominant irritable bowel syndrome (C-IBS), opioid-induced constipation, functional dyspepsia, and diabetic gastroparesis.

863186

C26H38N6O2

466.62

C(N[C@H]1C[C@@]2(N(CCN3CCN(C(C)=O)CC3)[C@](C1)(CC2)[H])[H])(=O)C=4C=5C(N(C(C)C)N4)=CC=CC5

-20°C

Ice Packs

Small Compound